drugset / Trial / NCT04199598
Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.
RandomizedCrossoverOpen-labelBasic science
Summary
The study is intended to assess the relative bioavailability of 2 different abediterol nebulised formulations (test) and the dry powder formulation (reference). The study results will provide information on the pharmacokinetic (PK) profile following use of the 3 devices to be used in further clinical development.
Timeline
- Start
- 2020-01-28
- Primary completion
- 2020-04-03
- Completion
- 2020-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abediterol | Small molecule | 2.4 ug | Inhaled |
| Subject | Abediterol | Small molecule | 2.5 ug | Inhaled |
| Subject | Abediterol | Small molecule | 4.8 ug | Inhaled |